Achim K. Moesta

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

Achim K. Moesta, Paul J. Norman, Makoto Yawata et al. · The Journal of Immunology · 2008 · 383 citations · Full text

Life Sciences, Genetics, Immunology +17

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity

Xian-Yang Li, Achim K. Moesta, Christos Xiao et al. · Cancer Discovery · 2019 · 268 citations · Full text

Medicine, Immunology, Oncology +17

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C

Thorsten Graef, Achim K. Moesta, Paul J. Norman et al. · The Journal of Experimental Medicine · 2009 · 235 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes

Paul J. Norman, Laurent Abi‐Rached, Ketevan Gendzekhadze et al. · Genome Research · 2009 · 124 citations · Full text

Life Sciences, Genetics, Immunology +17

Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands

Ketevan Gendzekhadze, Paul J. Norman, Laurent Abi-Rached et al. · Proceedings of the National Academy of Sciences · 2009 · 117 citations

Life Sciences, Genetics, Immunology +17